Comparative Pharmacology
Head-to-head clinical analysis: COLOVAGE versus CONSTILAC.
Peer-Reviewed Evidence
Head-to-head clinical analysis: COLOVAGE versus CONSTILAC.
COLOVAGE vs CONSTILAC
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
COLOVAGE is a bowel cleansing preparation containing polyethylene glycol 3350 and electrolytes. It acts as an osmotic laxative, causing fluid retention in the colon to stimulate bowel evacuation.
Constilac (lactulose) is a synthetic disaccharide that is not absorbed in the small intestine. In the colon, it is metabolized by bacteria to short-chain fatty acids (e.g., lactic acid), which osmotically draw water into the bowel, producing a laxative effect. Additionally, in hepatic encephalopathy, the acidification of colonic contents traps ammonia (NH3) as ammonium (NH4+), reducing its absorption.
4 liters of PEG-3350 electrolyte solution orally as a single dose for colon cleansing prior to colonoscopy; alternatively, 2 liters with ascorbic acid regimen.
Oral, 15-45 mL (10-20 g lactulose) once daily, titrated to produce 2-3 soft stools daily; may be given as a single dose or divided twice daily. Onset of action 24-48 hours.
None Documented
None Documented
Not applicable (non-absorbed, gut lavage); systemic absorption minimal
Not applicable due to negligible systemic absorption; lactulose acts locally in the colon.
Primarily fecal as unabsorbed drug; negligible renal excretion (<5%)
Primarily fecal as unchanged drug (systemic absorption negligible). Renal excretion accounts for <2% of any absorbed fraction. Biliary excretion is minimal.
Category C
Category C
Osmotic Laxative
Osmotic Laxative